Two of Novo Nordisks key products are injectable drugs Ozempic and Wegovy, comprising the same active ingredient, semaglutide, in different doses
[1] [2] Most headaches associated with these treatments are mild to moderate in intensity and tend to occur during the initial weeks of treatment or following dose escalation
However, **this is theory, not proven fact in humans for Tirzepatide.** * **Potential Indirect Concerns:** Some resources also raise concerns that the medications side effects on the mother (like nausea, vomiting, diarrhea, decreased appetite leading to significant caloric deficit) could potentially impact hydration, milk supply, or even the nutrient density of breast milk, although this also requires more research
What to look for: Active, unrestricted license status
Side effect sensitivity: Nausea, bloating, constipationthese can be tough to handle